D-Keine Deals and Financings Hangzhou Sciwind Biosciences out-licensed South Korean rights for ecnoglutide injection (XW003), a novel long-acting GLP-1 analog aimed at type 2 diabetes, obesity and MASH, to HK inno.N Corporation (KOSDAQ: 195940). HK inno.N is a South Korean commercial stage pharmaceutical company. Sciwind will receive an unspecified upfront payment and additional milestones of…
NASHVILLE, February 6, 2024 – HIVE Digital Technologies Ltd (NASDAQ: HIVE) and Bitcoin Magazine announce “FUD Fighters”, a new initiative centered around education on the many false narratives articulated by critics of Bitcoin. The “FUD Fighters” series will consist of four in-depth research articles written by industry experts to counter erroneous, biased and misinformed narratives…
As it prepares to finalize the acquisition of Hess, Chevron will announce its 37th year of dividend growth in January. Brandon Bell This is the latest in my series of articles where I provide predictions of annual dividend increases for long-term dividend growth companies. At the end of November, I provided predictions for 18 dividend…
The collaboration between Osmosis and the UX chain will focus on addressing potential security vulnerabilities and shared liquidity to enhance growth prospects. The ultimate growth of blockchain technology has been pegged to the multi-chain capabilities, whereby the Cosmos (ATOM) network has described it as blockchain 3.0. In the context of multichain capabilities, Osmosis (OSMO), a…
With one of the best known brands in the world, Nike will increase its dividend growth streak to 23 years with its next boost in the second half of November. Thank you for your assistant This is the latest in my series of articles where I provide predictions of annual dividend increases for long-term dividend…
kentoh/iStock via Getty Images Deals and Financings Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate against Human Epidermal Growth Factor Receptor 3 (HER3) to BioNTech (BNTX) in a $1.1 billion agreement (see story). BioNTech will pay $70 million upfront to MediLink and be responsible for more than $1 billion in milestone…
Despite having to continually invest in new technologies, Verizon should announce its 18th year of dividend growth in late August. Cindy Ord This is the latest in my series of articles where I provide predictions of annual dividend increases for a variety of long-term dividend growth companies. At the end of June, I provided predictions…